Extravasation, lamina propria flooding and lumenal entry of bulk plasma exudate in mucosal defence, inflammation and repair

Pulmonary Pharmacology

Volumn 9, Issue 3, 1996, Pages 129-139

  Persson, C G A ^a   Erjefalt J S ^a   Andersson, M ^a   Greiff, L ^a   Svensson, C ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC REACTION; EXTRAVASATION; EXUDATE; HOST RESISTANCE; INFLAMMATION; LAMINA PROPRIA; MICROCIRCULATION; NOSE MUCOSA; PLASMA; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; REVIEW;

EID: 0030175141     PISSN: 09520600     EISSN: None     Source Type: Journal    
DOI: 10.1006/pulp.1996.0015     Document Type: Review

References (69)

1. 1. Cohnheim J. Vorlesungen ueber allgemeine Pathologie I. Berlin: Hirschwald 1882: 232-367.
2. 2. Persson C G A. Airway epithelium and microcirculation. Eur Respir Rev 1994; 4: 352-362.
3. 3. Jezierski P V. Zur Pathologie des Asthma Bronchiale. Deutsch Arch Klin Med 1906; 85: 342-347.
4. 4. Sobin S S, Frasher W G, Tremer H M, Madley G G. The microcirculation of the tracheal mucosa. Angiology 1963; 14: 165-170.
5. 5. Persson G C A. In vivo veritas. Thorax 1996; 51: 441-443.
6. 6. McDonald M. Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli. Am J Physiol 1994; 266: L61-83.
7. 7. Persson C G A, Svensson C, Greiff L, Andersson M, Wollmer P, Alkner U, Erjefält I. Editorial. The use of the nose to study the inflammatory response of the respiratory tract. Thorax 1992; 47: 993-1000.
8. 8. Hultström D, Svensjö E. Intravital and electron microscopic study of bradykinin-induced vascular permeability changes using FITC-dextran as a tracer. J Pathol 1979; 129: 125-133.
9. 9. Erjefält J S, Sundler F, Persson C G A. Eosinophils, neutrophils and venular gaps in the airway mucosa at epithelial removal-restitution. Am J Respir Crit Care Med 1996; 153: 1666-1674.
10. 10. Feng D, Nagy J A, Hipp J, Dvorak H F, Dvorak A M. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 1996; 183: 1981-1986.
11. 11. Grega G J, Persson C G A, Svensjö E. Endothelial cell reactions to inflammatory mediators assessed in vivo by fluid and solute flux analysis. In Ryan U S, ed. Endothelial Cells. Boca Raton, FL: CRC, 1988: 103-122.
12. 12. Persson C G A, Svensjö E. Vascular responses and their suppression: drugs interfering with venular permeability. In Bonta I L, Bray M A, Parnham M J, eds. Handbook of inflammation, vol 5. Amsterdam: Elsevier, 1985: 61-82.
13. 13. Brattsand R, Selroos O. Current drugs for respiratory diseases. Glucocorticoids. Drugs and the Lung 1994; ?: 101-220.
14. 14. Greiff L, Andersson M, Svensson C, Alkner U, Persson C G A. Glucocorticoids may not inhibit plasma exudation by direct vascular antipermeability effects in human airways. Eur Respir J 1994; 7: 1120-1124.
15. 15. Persson C G A. Plasma exudation and asthma. Lung 1988; 166: 1-23.
16. 16. Persson C G A, Erjefält I, Andersson P. Leakage of macromolecules from guinea-pig tracheobronchial microcirculation. Effects of allergen, leukotrienes, tachykinins and anti-asthma drugs. Acta Physiol Scand 1986; 127: 95-105.
17. 17. Erjefält I, Persson C G A. Pharmacological control of plasma exudation into tracheobronchial airways. Am Rev Respir Dis 1991; 143: 1008-1014.
18. 18. Svensson C, Greiff L, Andersson M, Alkner U, Grönneberg R, Persson C G A. Antiallergic actions of high topical doses of terbutaline in human nasal airways. Allergy 1995; 50: 884-890.
19. 19. Erjefält J S, Erjefält I, Sundler F, Persson C G A. Epithelial pathway for luminal entry of bulk plasma. Clin Exp Allergy 1995; 25: 187-195.
20. 20. Persson C G A, Andersson M, Greiff L, Svensson C, Erjefält J S, Sundler F, Wollmer P, Alkner U, Erjefält I, Gustafsson B, Linden M, Nilsson M. Airway permeability. Clin Exp Allergy 1995; 23: 807-814.
21. 21. Persson C G A, Erjefält I, Alkner U, Baumgarten C, Greiff L, Gustafsson B, Luts B, Pipkorn U, Sundler F, Svensson C, Wollmer P. Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy 1991; 21: 17-24.
22. 22. Persson C G A, Alkner U, Andersson M, Greiff L, Linden M, Svensson C. Histamine challenge-induced "lamina propria lavage" and mucosal out-put of IL-6 in human airways. Eur Respir J 1995; 8: Suppl 19: 125s.
23. 2-macroglobulin. Immunol Today 1990; 11: 163-166.
24. 24. Persson C G A, Erjefält I, Gustafsson B, Luts A. Subepithelial hydrostatic pressure may regulate plasma exudation across the mucosa. Int Arch Allergy Appl Immunol 1990; 92: 148-153.
25. 25. Gustafsson B G, Persson C G A. Asymmetrical effects of increases in hydrostatic pressure on macromolecular movement across the airway mucosa. A study in guinea-pig tracheal tube preparation. Clin Exp Allergy 1991; 21: 121-126.
26. 26. Svensson C, Baumgarten C R, Pipkorn U, Alkner U, Persson C G A. Reversibility and reproducibility of histamine-induced plasma leakage in the human nasal airways. Thorax 1989; 44: 13-18.
27. 27. Greiff L, Alkner U, Pipkorn U, Persson C G A. The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy 1990; 20: 253-259.
28. 28. Erjefält I, Persson C G A. Inflammatory passage of plasma macro molecules into airway tissue and lumen. Pulm Pharmacol 1989; 2: 93-102.
29. 29. Prescott T, Kaliner M A. Vascular mechanisms in rhinitis. In Busse W W, Holgate S T, eds. Asthma and rhinitis. Oxford: Blackwell, 1995: 777-790.
30. 30. Greiff L, Svensson C, Andersson M, Persson C G A. Effects of topical capsaicin in seasonal allergic rhinitis. Thorax 1995; 50: 225-229.
31. 31. Bascom R, Kagey-Sobotka A, Proud D. Effect of intranasal capsaicin on symptoms and mediator release. J Pharmacol Exp Ther 1991; 259: 1323-1327.
32. 32. Greiff L, Erjefält I, Wollmer P, Andersson M, Pipkorn U, Alkner U, Persson C G A. Effects of nicotine on the human nasal airway mucosa. Thorax 1993; 48: 651-655.
33. 2-macroglobulin into human bronchi. Am J Respir Crit Care Med 1996; 153: A290.
34. 34. Persson C G A, Erjefält I. Inflammatory leakage of macromolecules from the vascular compartment into the tracheal lumen. Acta Physiol Scand 1986; 126: 615-616.
35. 35. Minnicozzi M, Durán W N, Gleich G J, Egan R W. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J Immunol 1994; 153: 2664.
36. 36. Salomonsson P, Grönneberg R, Gilljam H, Andersson O, Billing B, Enander I, Alkner U, Persson C G A. Bronchial exudation of bulk plasma at allergen challenge in allergic asthma. Am Rev Respir Dis 1992; 146: 1535-1542.
37. 37. Svensson C, Grönneberg R, Andersson M, Alkner U, Andersson O, Billing B, Gilljam H, Greiff L, Persson C G A. Allergen challenge-induced entry of alpha-2-macroglobulin and tryptase into human nasal and bronchial airways. J Allergy Clin Immunol 1995; 96: 239-246.
38. 38. Pipkorn U, Proud D, Schleimer R P, et al. Effects of short term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest 1987; 80: 957-961.
39. 39. Erjefält I, Greiff L, Alkner U, Persson C G A. Allergen-induced biphasic plasma exudation responses in guinea-pig large airways. Am Rev Respir Dis 1993; 148: 695-701.
40. 40. Persson C G A. Airway microcirculation, epithelium and glucocorticoids. In Schleimer, Busse, O'Byrne, eds (Lung Biology Health Dis-series). Topical glucocorticoids in asthma: mechanisms and clinical actions. New York: Dekker, 1996: 167-201.
41. 41. Persson C G A, Gustafsson B, Luts A, Sundler F, Erjefält I. Toluene diisocyanate produces an increase in airway tone that outlasts the inflammatory exudation phase. Clin Exp Allergy 1991; 21: 715-724.
42. 42. Erjefält I, Persson C G A. Increased sensitivity to toluene diisocyanate (TDI) in airways previously exposed to low doses of TDI. Clin Exp Allergy 1992; 22: 854-862.
43. 43. Fabbri L M, Mapp C. Bronchial hyperresponsiveness, airway inflammation and occupational asthma induced by toluene diisocyanate. Clin Exp Allergy 1991; 21: 42-41.
44. 44. Boschetto P, Fabbri L M, Zocca E, et al. Prednisone inhibits late asthmatic reactions and airway inflammation induced by toluene diisocyanate in sensitized subjects. J Allergy Clin Immunol 1987; 80: 261-267.
45. 45. Persson C G A. Airway mucosal exudation of plasma. In Takishima T, Shimura S, eds. Airway secretion. Physiological bases for the control of mucous hypersecretion. New York: Dekker, 1994; 72: 451-468.
46. 46. Persson C G A. Permeability changes in obstructive airway diseases. In Sluiter H J, Van der Lende, eds. Bronchitis IV. Assen: Van Gorcup 1989c: 236-248.
47. 47. Webber S E, Widdicombe J G. The transport of albumin across the ferret in vitro whole trachea. J Physiol 1989; 408: 457-472.
48. 48. Van de Graaf E A, Out T A, Roos C M, Jansen H M. Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Effects of therapy with inhaled steroids. Am Rev Respir Dis 1991; 143: 362-368.
49. 49. Svensson C, Klementsson H, Andersson M, Pipkorn U, Alkner U, Persson C G A. Glucocorticoid-reduced attenuation of mucosal exudation of bradykinins and fibrinogen in seasonal allergic rhinitis. Allergy 1994; 49: 177-183.
50. 50. Persson C G A, Pipkorn U. Glucocorticoids. In Waksman B H, ed. Fifty years progress in allergy. Basel, Karger: Chem Immunol, 1990; 49: 264-277.
51. 51. Farr B M, Gwaltney J M Jr, Hendley J O. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990; 162: 1173-1177.
52. 52. Erjefält J S, Erjefält I, Sundler F, Persson C G A. Effects of topical budesonide on epithelial restitution in vivo in guinea-pig trachea. Thorax 1995; 50: 785-792.
53. 53. Tang L, Eaton J W. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 1993; 178: 2147-2156.
54. 54. Erjefält J S, Erjefält I, Sundler F, Persson C G A. Microcirculation-derived factors in airway epithelial repair in vivo. Microvascular Research 1994; 48: 161-178.
55. 55. Persson C G A, Erjefält J S, Erjefält I, Korsgren M, Nilsson M, Sundler F. Epithelial shedding-restitution as a causative process in airway inflammation. J Clin Exp Allergy 1996; 26: 746-755.
56. 56. Persson C G A. Role of plasma exudation in asthmatic airways. Lancet 1986; 2: 1126-1129.
57. 57. Svensson C, Andersson M, Greiff L, Persson C G A. Day-night differences in mucosal plasma proteins in common cold. Acta Oto-Laryngol 1996; 116: 85-90.
58. 58. Hutt G, Wick H. Bronchial-lumen and Atemwiderstand. Z Aerosol Forsch Ther 1956; 5: 131-140.
59. 59. Svensson C, Andersson M, Greiff L, Alkner U, Persson C G A. Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis. Clin Exp Allergy 1995; 25: 942-950.
60. 60. Elwood R K, Kennedy S, Belzberg A, Hogg J C, Paré P D. Respiratory mucosal permeability in asthma. Am Rev Respir Dis 1983; 129: 523-527.
61. 113mIn-DTPA in asthma and the effects of salmeterol. Eur Respir J 1993; 6: 512s.
62. 62. Greiff L, Wollmer P, Svensson C, Andersson M, Persson C G A. Effect of seasonal allergic rhinitis on airway mucosal absorption of Chromium-51-labelled EDTA. Thorax 1993; 48: 648-650.
63. 63. Erjefält J S, Korsgren M, Nilsson M C, Sundler F, Persson C G A. Prompt epithelial damage-and restitution-processes in allergen challenged guinea-pig trachea. Clin Exp Allergy 1996; in press.
64. 64. Wilhelm D L. Regeneration of tracheal epithelium. J Pathol Bacteriol 1953; 65: 543-550.
65. 65. Erjefält J S, Erjefält I, Sundler F, Persson C G A. In vivo restitution of airway epithelium. Cell Tissue Res 1995; 281: 305-316.
66. 66. Erjefält J S, Erjefält I, Sundler F, Persson C G A. Mucosal nitric oxide may tonically suppress airways plasma exudation. Am J Respir Crit Care Med 1994; 150: 227-232.
67. 67. Erjefält J S, Greiff L, Sundler F, Persson C G A. Basal cells promptly flatten out at detachment of the columnar epithelium in human and guinea-pig airways. Eur Respir J 1995; 8: Suppl 19: 207s.
68. 68. Persson C G A, Erjefält J S. Airway epithelial restitution following shedding and denudation. In Crystal R G, West J B, Weibel E R, Barnes P J, eds. The Lung: Scientific foundations, 2nd edn. New York: Raven, in press.
69. 69. Erjefält J S, Persson C G A. Free eosinophil granules in airway diseases: an in vivo paradigm for cell activation and drug development. Submitted.